Scilex Holding Company (SCLXW)

USD 0.21

(-23.88%)

Inventory Summary of Scilex Holding Company

Scilex Holding Company's latest annual inventory in 2023 was 4.21 Million USD , up 205.81% from previous year.
Scilex Holding Company's latest quarterly inventory in 2024 Q1 was 3.48 Million USD , down -17.28% from previous quarter.
Scilex Holding Company reported annual inventory of 1.37 Million USD in 2022, down -46.21% from previous year.
Scilex Holding Company reported annual inventory of 2.56 Million USD in 2021, up 123.76% from previous year.
Scilex Holding Company reported quarterly inventory of 3.07 Million USD for 2024 Q2, down -11.85% from previous quarter.
Scilex Holding Company reported quarterly inventory of 2.27 Million USD for 2023 Q1, up 65.09% from previous quarter.

Annual Inventory Chart of Scilex Holding Company (2023 - 2020)

Historical Annual Inventory of Scilex Holding Company (2023 - 2020)

Year	Inventory	Inventory Growth
2023	4.21 Million USD	205.81%
2022	1.37 Million USD	-46.21%
2021	2.56 Million USD	123.76%
2020	1.14 Million USD	0.0%

Year	Inventory	Inventory Growth
2024 Q1	3.48 Million USD	-17.28%
2024 Q2	3.07 Million USD	-11.85%
2023 Q1	2.27 Million USD	65.09%
2023 Q3	3.94 Million USD	26.75%
2023 FY	4.21 Million USD	205.81%
2023 Q4	4.21 Million USD	6.9%
2023 Q2	3.11 Million USD	36.7%
2022 FY	1.37 Million USD	-46.21%
2022 Q2	1.16 Million USD	-40.21%
2022 Q3	933 Thousand USD	-19.57%
2022 Q4	1.37 Million USD	47.7%
2022 Q1	1.94 Million USD	-24.28%
2021 Q2	640.5 Thousand USD	0.0%
2021 Q1	640.5 Thousand USD	123.76%
2021 Q3	640.5 Thousand USD	0.0%
2021 FY	2.56 Million USD	123.76%
2021 Q4	2.56 Million USD	300.0%
2020 Q3	286.25 Thousand USD	0.0%
2020 Q4	286.25 Thousand USD	0.0%
2020 FY	1.14 Million USD	0.0%
2020 Q2	286.25 Thousand USD	0.0%
2020 Q1	286.25 Thousand USD	0.0%

Peer Inventory Comparison of Scilex Holding Company

Name	Inventory	Inventory Difference
Amgen Inc.	9.51 Billion USD	99.956%
AstraZeneca PLC	5.42 Billion USD	99.922%
Biogen Inc.	2.52 Billion USD	99.833%
Gilead Sciences, Inc.	3.36 Billion USD	99.875%
MIRA Pharmaceuticals, Inc.	-11.86 Thousand USD	35625.207%
Scilex Holding Company	4.21 Million USD	0.0%